More on BORAY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.25 |
|
|||
| Open | $2.25 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.25 | ||||
| Day Low | $2.25 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,490,574 | ||||
- UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
- MacroGenics to sell manufacturing operations to Bora for $122.5 million
- UPSHER-SMITH LAUNCHES NEW ONLINE RESOURCES TO SUPPORT THE DUCHENNE COMMUNITY
- UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
- Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Entities mentioned with BORAY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
